STEVEN M. KLOSK - Corporate Board Profile

LISATA THERAPEUTICS, INC.

Filing Date	Source Excerpt
2014-08-29	Steven M. Klosk was appointed to serve as an independent member of our Board of Directors effective as of July 8, 2014, at which time the size of the Board was expanded from seven directors to eight directors. Since 2008, Mr. Klosk has served as President, CEO & Director at Cambrex Corporation (NYSE:CBM), a NYSE listed company with annual revenues of approximately $315 million and one of the leading providers of active pharmaceutical ingredients, advanced intermediates and finished dosage form products to the branded and generic pharmaceutical markets.
2015-06-08	Our Compensation Committee consists of four directors: Mssrs. Berman (chairperson), Myers, Klosk and Wei. Each such member of the Compensation Committee is independent applying the definition of independence under the listing standards of NASDAQ and SEC regulations. The Compensation Committee meets at least two times during each year. Our Nominating and Governance Committee consists of three directors: Mssrs. Myers (chairperson), Klosk and Traber. The Nominating and Governance Committee is empowered by the Board to recommend to the Board qualified individuals to serve on the Board and to identify the manner in which the Nominating and Governance Committee evaluates nominees recommended for the Board. All members of the Nominating and Governance Committee have been determined to be “independent directors” pursuant to the definition contained in the rules of NASDAQ and SEC regulations. At December 31, 2014, Mr. Klosk had options to purchase 18,700 shares of our common stock, all of which were vested. At December 31, 2014, Mr. Klosk had a total of 10,000 shares in stock awards outstanding, all of which were vested. The following table sets forth information on all compensation to NeoStem's directors (other than as reflected in the Summary Compensation Table) for the year ended December 31, 2014. Steven Klosk (7) 2014 $20,000 — $67,834 $87,834
2016-05-10	Steven M. Klosk Mr. Klosk joined the Board in 2014. He is a senior executive with extensive management experience in the life sciences industry. He is currently President, CEO and a Director at Cambrex Corporation (NYSE:CBM)... The Audit Committee consists of three directors: Messrs. Wei (chairperson), Myers and Klosk... Our Compensation Committee consists of three directors: Messrs. Klosk (chairperson), Myers and Wei... Our Nominating and Governance Committee consists of three directors: Messrs. Myers (chairperson), Klosk and Dr. Traber... The following table sets forth information on all compensation to Caladrius' directors (other than as reflected in the Summary Compensation Table) for the year ended December 31, 2015... Steven Klosk (7) $40,000 $67,360 $0 $107,360
2018-04-24	Steven M. Klosk joined the Caladrius Board in 2014. ... The Audit Committee consists of three directors: Dr. Brown (Chairman), and Messrs. Klosk and Myers. ... Our Compensation Committee consists of four directors: Mr. Klosk (Chairman), Dr. Brown, Mr. Myers and Dr. Traber. ... The following table sets forth information on all compensation to Caladrius' directors (other than as reflected in the Summary Compensation Table) for the year ended December 31, 2017. ... Steven M. Klosk $64,500 cash fees, $19,615 stock awards, $6,380 option awards, total $90,495.
2019-04-30	Steven M. Klosk joined the Caladrius Board in 2014. He is a senior executive with extensive management experience in the life sciences industry. He is currently President, CEO and a Director at Cambrex Corporation (NYSE:CBM). The Audit Committee consists of four directors: Dr. Brown (Chairman), Messrs. Klosk and Myers and Ms. Schwalm. The Compensation Committee consists of four directors: Mr. Klosk (Chairman), Dr. Brown, Mr. Myers and Dr. Traber. The following table sets forth information on all compensation to Caladrius' directors for the year ended December 31, 2018. Steven M. Klosk: Fees Earned in Cash $64,500, Stock Awards $33,151, Total Compensation $106,402.
2020-04-29	Mr. Klosk joined the Caladrius Board in 2014. He is currently CEO and a Director at Cambrex Corporation. The Audit Committee consists of four directors: Dr. Brown (Chairman), Messrs. Klosk and Myers and Ms. Schwalm. The Compensation Committee consists of four directors: Mr. Klosk (Chairman), Dr. Brown, Mr. Myers and Dr. Traber. The Science and Technology Committee consists of Drs. Traber (Chairman), Brown, Mazzo, Mr. Klosk and Ms. Schwalm. The following table sets forth information on all compensation to Caladrius' directors (other than as reflected in the Summary Compensation Table) for the year ended December 31, 2019. Steven M. Klosk: Fees Earned or Paid in Cash $64,500; Stock Awards $59,999; Total Compensation $124,499.
2021-04-28	Steven M. Klosk joined the Caladrius Board in 2014. ... The Audit Committee consists of four directors: Dr. Brown (Chairman), Messrs. Klosk and Myers and Ms. Schwalm. ... Our Compensation Committee consists of four directors: Mr. Klosk (Chairman), Dr. Brown, Mr. Myers and Ms. Whitaker. ... The Science and Technology Committee consists of Drs. Davidson (Chairman), Brown, Traber, Mazzo, Mr. Klosk, Ms. Schwalm and Ms. Whitaker. ... The following table sets forth information on all compensation to Caladrius' directors (other than as reflected in the Summary Compensation Table) for the year ended December 31, 2020. ... Steven M. Klosk $64,500 Fees Earned in Cash, $59,998 Stock Awards, $0 Option Awards, $124,498 Total Compensation.